Alemtuzumab Approved For Multiple Sclerosis

The FDA has approved alemtuzumab (Lemtrada) as a treatment for patients with multiple sclerosis. The FDA was careful to cite that use of alemtuzumab was a high-risk option since the drug may cause an increased risk for malignancies, including thyroid cancer, melanoma, lymphoproliferative disorders, neuropathy, which in some instances proved fatal. The medication is also marketed as Campath, which […]

Virus-Induced Neuropathy

Recent dramatic study highlights the fact that some neuropathies can be caused by viruses. In this case the virus is known as Dinocampus coccinellae paralysis virus (DcPV), which is a single-stranded, positive-sense RNA virus unique to insects. The virus creates a “zombie ladybug” by inducing a neuropathy that spreads to the ladybug’s entire nervous system and paralyzing […]

Neuropathic Pain Treatment

European scientists at the Pain Evaluation and Treatment Centre of Hôpital Ambroise Paré, evaluated several medications for neuropathic pain in an article partially titled “Pharmacotherapy for neuropathic pain in adults“. While research reports and findings are peer-reviewed for scientific correctness, the director of the center, Dr.Nadine Attal, finds certain biases creep into the picture. For […]